Member Info for TimmyTradeface

'Collaboration with Dr Reddies - Billion Dollar pharmaceutical Company. FACT'

Wrong. That collaboration was mutually terminated earlier this year.

It has already been paid. It was hidden in the depths of the last RNS.

'Kodal has continued to work closely with the Mali government to progress the Mining Licence Application, and as previously announced, has both received the request for and paid the Mining Licence Application fee. '

If it went up 50% there would probably be a reason, so the answer would be yes, but if you put the 6 month charts together, only major events show a matching increase. These little pre-market up 5/10%s you keep commenting on do not reflect in our share price. There is a lot more liquidity in the US, presumably due to a larger number of investors. Their price fluctuates a lot, we usually get less than 10 trades a day which rarely changes the SP.

Surely by now you've been watching long enough to realise there is no correlation with nasdaq sp movement and lse's sp...

Meant to say 'can', not can't.

Perhaps you should consider stopping investing in stocks tryharder. If you can't cope emotionally with the ups and downs and are losing money as a result you're in the wrong game, for the sake of your finance and mental well-being. It can't get a heck of a lot worse than this stock, believe me...

Rocky B*stard, Hotel California and Seabiscuit will be the next areas they seek licences for.

It's what Stampy gave as an estimate in an interview, but nothing certain. I'm not sure if it was based on the Dr. Reddys collab but hopefully not because that's no more. Would be nice to get some positive news re: the unnamed global pharma before the quarter ends.

Where's whatamess today? He needs to come along and tell us that pigeons are carrying a 10x deadlier Covid variant and the sp will hit 50p.

I think it's probably an older interview to be honest, Gray. I can't see them declaring via an official RNS that the partnership is off then stating it's back on in an unofficial interview without informing shareholders.

I think as the dollar weakens they might be paying more attention to foreign companies. Also there is the massive population difference between us and the US. That's two theories I have. Another is that the US investors might just be a bit more Gung Ho/Confident about throwing money about... All speculation though.

The site doesn't know which is a buy or a sell, so it has to guess based on what side of the mid price the value of the transaction was, and often it gets it wrong. Sometimes when I buy shares I get them for less than the mid price on LSE at the time and it registers as a sell. I don't think the site is trying to be misleading or manipulative (at least in this regard...).

FCA rather* Although the FDA probably won't care much for it either.

Don't get me wrong, I used to sometimes behave like you when I was 13, but this bulletin board isn't the place for it. Find a Minecraft forum or something (or whatever kids are into these days). And claiming to be able to control a share price is market abuse which isn't looked on fondly by the FDA - be careful.

That's great, but you can stop the spam now. And fix your caps lock...

The US always seem so much better at lifting sp than us Brits. It's either greater enthusiasm, or a much larger population of traders/investors...

I've taken profit; I never put too much faith into rises without news, particularly with this stock which hasn't historically held gains. Might get back in if it sinks back down, but good luck to those still holding - I hope it serves you well!

'The present invention provides a nano particle comprising: a core comprising metal atoms; a corona comprising a plurality of ligands covalently linked to the core, wherein said plurality of ligands comprises: at least one carbohydrate ligand; at least one glutathione ligand; and at least one autoantigen peptide ligand. Also provided are compositions and vaccines comprising the nanoparticles, methods for producing the nanoparticles and medical uses of the nanoparticles, including for antigen specific immunotherapy of an autoimmune disease, such as diabetes mellitus type 1, in a mammalian subject.'

I'm no biology expert but my interpretation in layman's terms is that it's the patent that protects the use of nanoparticles in vaccines. I could be totally wrong; a more professional opinion is welcome. If that is correct, this could allude to the technology Emergex is using - again, speculation on my behalf.

It's bizarre to see the sp falling like a failing company despite the release of such good results and strong outlook for the future. It's certainly got me scratching my head.

Even if RYCEY isn't the next one they target, I can't help but wonder if people starting jumping into Rolls with the intent of getting in before the rest of the herd (even if the rest of herd never actually comes).